Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma

Cancer

Volumn 104, Issue 1, 2005, Pages 183-190

  Mazzoleni, Stefano ^a   Bisogno, Gianni ^b   Garaventa, Alberto ^c   Cecchetto, Giovanni ^b   Ferrari, Andrea ^d   Sotti, Guido ^b   Donfrancesco, Alberto ^e   Madon, Enrico ^f   Casula, Letizia ^g   Carli, Modesto ^b,h  

^a Camposampiero Hospital   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g Hospital of Cagliari   (Italy)

^h Division of Hematology Oncology   (Italy)

Author keywords

Nonalveolar histology; Prognostic factors; Recurrence; Rhabdomyosarcoma

Indexed keywords

ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOSARCOMA; RISK FACTOR; SALVAGE THERAPY; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RHABDOMYOSARCOMA; RISK FACTORS; TIME FACTORS;

EID: 20544459342     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21138     Document Type: Article

References (13)

1. Carli M, De Bernardi B, Castello M, et al. Long-term results in childhood rhabdomyosarcoma: a retrospective study in Italy. Pediatr Hematol Oncol. 1986;3:371-378.
2. Crist W, Gehan EA, Ragab AH, et al. The Intergroup Rhabdomyosarcoma Study-III. J Clin Oncol. 1995;13:610-630.
3. Stevens MCG, Rey A, Bouvet N, et al. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence. Results of the third study of the International Society of Paediatric Oncology-STOP Malignant Mesenchymal Tumor 89. J Clin Oncol. 2005;23:2618-2628.
4. Koscielniak E, Harms D, Henze G, et al. Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol. 1999;17:3706-3719.
5. Crist WM, Anderson JR, Meza JL, et al. Intergroup Rhabdomyosarcoma Study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001;19:3091-3102.
6. Pappo AS, Anderson JR, Crist WM, et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol. 1999;17:3487-3493.
7. Kaplan E, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457-481.
8. Peto R, Pike M, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: I - Analysis and examples. Br J Cancer. 1977; 35:1-39.
9. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
10. Flamant F, Rodary C, Rey A, et al. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer. 1998;34:1050-1062.
11. Godzinsky J, Flamant F, Rey A, et al. Value of postchemotherapy bioptical verification of complete clinical remission in previously incompletely resected malignant mesenchymal tumors in children: STOP 84 malignant mesenchymal tumours study. Med Pediatr Oncol. 1994;22: 22-26.
12. Hingebiel T, Pertl U, Hess C, et al. Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial. Med Pediatr Oncol. 1998;30:269-275.
13. Raney RB Jr., Crist WM, Maurer HM, Foulkes MA, for the Intergroup Rhabdomyosarcoma Committee. Prognosis of children with soft tissue sarcoma who relapse after achieving a complete response. A report from the Intergroup Rhabdomyosarcoma Study I. Cancer. 1983;52:44-50.